light from 210-
259nm acc. to
USP
Sodium iodide in purified water
(667-UV10: wavelength [nm] 259
(cut-off), pathlength 10 mm)
Sodium iodide in purified water
reference filter (667-UV10H:
UV10, UV10H
para ensayo de
la luz parásita
a partir de
210 - 259 nm
según la
USP
Yoduro de sodio en agua purificada
(667 - UV10: longitud de onda [nm]
259 (valor de
calcium alginate beads Plant Sci. 58, 203-
210 (1988)
S: 22-24/25
i-Carrageenan
1 g
25 g
C 3799
F
(Irish moss; Gelatin, vegetable)
CAS No. 9062-07-1
Eucheuma spinosa, Type V
Prepared from a
Riobo, N.A., and Manning, D.R. Biochem. J. 2007; 403:369
5. Athar, M., et al. Exp. Dermatol. 2006; 15:667.
6. Jiang, J. Cell Cycle 2006; 5:2457.
7. Simms-Mourtada, J., et al. Clin. Cancer Res. 2006; 12:6565
to 100 ml with mobile phase.
Pressure Drop: 46 bar (667 psi)
Chromatographic Data
No. Compound Time Tailing Factor Theoretical Plate
1 Risedronate Na 3.9 1.4 5212
http://en.wikipedia.
in AD human brain by immunohistochemistry
using anti-APP (C-terminus, 1:100).
http://www.millipore.com/catalogue/item/07-667?cid=BI-XX-BRC-C-EPDF-ANTI-C108-1311
http://www.millipore.com/catalogue
activity of Elk1 by binding to ERK2, and prevents its interaction with MEK (IC50 = 210 nM).
Purity: ≥95% by HPLC.
1 mg € 208
ERK Inhibitor II 328007 A cell-permeable, potent, ATP-competitive inhibitor
0.0002 0.0002 210 (50%), 220 (80%),
245 (98%)1.04390.2500 2.5 L GL
1.04390.9010 10 L ST
1.04390.9030 30 L ST
1.04390.9185 185 L ST
n-Hexane 1.04391.1000 1 L GL 98.0 1 0.01 0.0002 0.0002 210 (50%), 220
G7670 25238 Adrbk1 M NP_036908.1 y n/d y
478 Myosin IX/Myr5 M5566 25486 Myo9b P NP_037116.1 n/d n/d y
667 Sin3A, N-terminal S4445 25942 SIN3A P NP_001138829.1 y y y
668 Sin3A, C-Terminal S6695 25942 SIN3A
G7670 25238 Adrbk1 M NP_036908.1 y n/d y
478 Myosin IX/Myr5 M5566 25486 Myo9b P NP_037116.1 n/d n/d y
667 Sin3A, N-terminal S4445 25942 SIN3A P NP_001138829.1 y y y
668 Sin3A, C-Terminal S6695 25942 SIN3A
G7670 25238 Adrbk1 M NP_036908.1 y n/d y
478 Myosin IX/Myr5 M5566 25486 Myo9b P NP_037116.1 n/d n/d y
667 Sin3A, N-terminal S4445 25942 SIN3A P NP_001138829.1 y y y
668 Sin3A, C-Terminal S6695 25942 SIN3A
S3056 P y n/d n/d
666 Siah2 S7945 M y y n/d
667 Sin3A, N-terminal S4445 P y y y
668 Sin3A, C-Terminal S6695 P y n/d n/d
669 Sir2S S5313 P n/d y n/d
670 SIRPα1 (SHPS-1) S1311 P n/d y y
671 Sirt1
Akt Inhibitor VIII, Isozyme-Selective,
Akti-1/2
124018 A cell-permeable potent and selective inhibitor of Akt1/Akt2 kinase activity (IC50 = 58 nM, 210 nM, and
2.12 mM for Akt1, Akt2, and Akt3, respectively
NP_002825.3 P y n/d n/d
666 Siah2 S7945 20439, 6478 Siah2,SIAH2 NP_033200.2,NP_005058.3 M y y n/d
667 Sin3A, N-terminal S4445 20466, 25942, 363067 Sin3a_predicted,SIN3A,Sin3a NP_035508.2,NP_056292.1,NP
NP_002825.3 P y n/d n/d
666 Siah2 S7945 20439, 6478 Siah2,SIAH2 NP_033200.2,NP_005058.3 M y y n/d
667 Sin3A, N-terminal S4445 20466, 25942, 363067 Sin3a_predicted,SIN3A,Sin3a NP_035508.2,NP_056292.1,NP
R IP WB Pur Rb IgG 200 µL 05-767
Anti-phospho-CREB (Ser133) 10E9 H M R WB Pur M IgG1κ 100 µg 05-667
Anti-phospho-CREB (Ser133 634-2 M R IF WB IC Pur M IgG 200 µg 05-807
Anti-CREB